Trial Profile
Diffusion tensor weighted MRI [magnetic resonance imaging] in Alzheimer's disease: Prediction and mapping of symptomatic and disease modifying treatment effects of galantamine (Reminyl)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 07 Sep 2007 New trial record.